Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery

NCT07147049 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Acute Postoperative Pain

Interventions

DRUG: HL-1186
DRUG: HL-1186 placebo

Sponsor

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.